Published • loading... • Updated
Bombshell Decision on Weight Loss Drugs
The Therapeutic Goods Administration approved the oral GLP-1 tablet, with more than 10,000 Australians already on a waiting list, officials said.
- On Tuesday, The Therapeutic Goods Administration approved the Wegovy pill, marking the first oral weight-loss drug cleared for use in Australia.
- Danish pharmaceutical giant Novo Nordisk submitted an application earlier this year following successful launches in the United States and Britain, where demand for the oral GLP-1 treatment surged.
- According to GP Wes Abujalala, patients must take the tablet first thing in the morning on an empty stomach and wait at least 30 minutes before consuming anything else.
- More than 10,000 Australians have already signed up to an online waiting list for the treatment, which is expected to be available before Christmas.
- Rival pharmaceutical company Eli Lilly has its own oral weight-loss drug, Orforglipro, currently awaiting a regulatory decision from the TGA, setting up future competition.
Insights by Ground AI
13 Articles
13 Articles
First Weight-Loss Tablet Approved for Use in Australia
Australians wanting to take weight-loss drugs will no longer have to inject themselves, with the first daily tablet version now medically approved. The Therapeutic Goods Administration cleared various doses of the Wegovy tablet, made by Danish pharmaceutical company Novo Nordisk, on Nov. 3. Previously, Australians had to take the GLP-1 weight-loss drug in the form of a weekly injection. The daily tablet form of the appetite-suppressing medicat…
·New York, United States
Read Full Article
Sydney Morning Herald+3 Reposted by 3 other sources
First weight loss pill gets approved in Australia
Australians living with obesity will soon have access to a daily weight-loss pill after the Therapeutic Goods Administration (TGA) approved a tablet version of Wegovy.
·North Sydney, Australia
Read Full Article
Coverage Details
Total News Sources13
Leaning Left4Leaning Right3Center3Last UpdatedBias Distribution40% Left
Bias Distribution
- 40% of the sources lean Left
40% Left
L 40%
C 30%
R 30%
Factuality
To view factuality data please Upgrade to Premium
